Novartis Q3 Non-GAAP EPS of $2.46 beats by $0.22; FY core operating income outlook upgraded
- Novartis press release (NVS): Q3 Non-GAAP EPS of $2.46 beats by $0.22.
- Revenue of $14.52B (+4.4% Y/Y) misses by $40M.
- Q3 net sales grew +4% (cc1, +4% USD), with core operating income1 +10% (cc, +11% USD).
- Q3 free cash flow1 was USD 5.1 billion (-18% USD).
- Full-year 2026 guidance raised for core operating income: Net sales expected to grow low single-digit (unchanged) (vs. estimated growth of 1.45% Y/Y). Core operating income expected to be in line to grow low single-digit (from decline low single-digit).
Recommended For You
Register for free to keep reading.
Create a free account to get unlimited breaking news and alerts when your stocks move.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.